Focused Ultrasound Featured in NIH’s Clinical Neuroscience Grand Rounds
Published:
Key Points Focused ultrasound was the topic of the November 12 Clinical Neuroscience Grand Rounds hosted by the National Institutes of Health (NIH). NIH Clinical Center Senior Scientist, Scott Burks, PhD, and Suzanne LeBlang, MD, the Foundation’s director of clinical relationships presented the latest research. The National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH), holds Clinical Neuroscience Grand Rounds each week. The format for the lecture series is a 30-minute case study presentation followed by a 60-minute main lecture. Attendees may join in person on the NIH campus (Building 10, Lipsett Amphitheatre), which includes a pre-lecture networking coffee session, or join virtually via Zoom. The November 12 Grand Rounds featured focused ultrasound research as the main topic. Suzanne LeBlang, MD, the Foundation’s Director of Clinical Relationships, led off the morning by presenting the state of the field for focused ultrasound and Alzheimer’s disease. Her talk provided an overview of research that has been done using focused ultrasound for either neuromodulation or blood-brain barrier opening (BBBO). Focused ultrasound BBBO allows the body’s immune system – either with or without enhanced drug delivery – to reach the brain and decrease the amount of amyloid. As a case example, Dr. LeBlang highlighted a patient reported in the 2024 New England Journal of Medicine article by Rezai, et al. where the side of the brain that received focused ultrasound after infusion of anti-amyloid antibodies had a significant decrease in amyloid compared with the side that did not receive the focused ultrasound sonications. In addition, she presented research from another mechanism of action, focused ultrasound neuromodulation (without BBBO), that resulted in decreased amyloid and cognitive improvement across various preclinical and clinical studies. Scott Burks, PhD, a senior scientist at the NIH Clinical Center, then presented his lecture titled, “The Neuroinflammatory Consequences of Blood-Brain Barrier Opening.” His talk shared the latest translational research investigating the mechanistic biology of ultrasound-tissue interactions. He also described his research on the sterile inflammatory response in the brain after focused ultrasound and how immune cells react to BBBO. His work centers around designing novel clinical applications for focused ultrasound. Both presentations are now available on the Foundation’s YouTube Channel. “This program was an exciting opportunity to share the latest clinical research with focused ultrasound and Alzheimer’s disease. Much of the translational work has been made possible by the seminal research performed by Dr. Burks and his colleagues. The entire program generated a lot of interest and great questions,” said Dr. LeBlang. For More Information on Focused Ultrasound for Alzheimer’s Disease In her presentation, Dr. LeBlang shared a recent review paper by Nadiyeh Rouhi et al. titled “A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer’s disease.” Read More About NINDS’ Clinical Neurosciences Grand Rounds Watch the Recording
Read More ...